Holmium-loaded PLLA nanoparticles for intratumoral radiotherapy via the TMT technique: Preparation, characterization, and stability evaluation after neutron irradiation

Drug Development and Industrial Pharmacy

Volumn 34, Issue 8, 2008, Pages 796-806

  Hamoudeh, Misara ^a   Fessi, Hatem ^a,d   Salim, Hani ^b   Barbos, Dumitru ^c  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSTITUTE FOR NUCLEAR RESEARCH   (Romania)

^d CPE LYON   (France)

Author keywords

Holmium; Irradiation; Nanoparticles; PLLA; Radionuclide; TMT technique; Tumor

Indexed keywords

HOLMIUM; HOLMIUM ACETYLACETONATE; NANOPARTICLE; POLYLACTIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CANCER RADIOTHERAPY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG STABILITY; EMULSION; ENTHALPY; EVAPORATION; INFRARED SPECTROSCOPY; MELTING POINT; NANOANALYSIS; NANOENCAPSULATION; NEUTRON RADIATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR REACTOR; PARTICLE SIZE; RADIOACTIVITY; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 49449085624     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040801918623     Document Type: Article

References (45)

1. Alevizaki, C., Molfetas, M., Samartzis, A., Vlassopoulou, B., Vassilopoulos, C., Rondogianni, P., Kottou, S., Hadjiconstantinou, V., & Alevizaki, M. (2006). Iodine 131 treatment for differentiated thyroid carcinoma in patients with end stage renal failure: Dosimetric, radiation safety, and practical considerations. Hormones (Athens), 5(4), 276-287.
2. Andratschke, M., Gildehaus, F. J., Johannson, V., Schmitt, B., Mack, B., Reisbach, G., Lang, S., Lindhofer, H., Zeidler, R., Wollenberg, B., & Luebbers, C. W. (2007). Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody. Anticancer Res., 27, 431-436.
3. Bladou, F., Thuret, R., Gravis, G., Karsenty, G., Serment, G., & Salem, N. (2007). Techniques, indications and results of permanent prostate brachytherapy for localized prostate cancer. Ann. Urol. (Paris), 41(2), 68-79.
4. Borbath, I., Lhommel, R., Bittich, L., Goffette, P., Annet, L., Van Beers, B. E., Bonny, M. A., Pauwels, S., & Horsmans, Y. (2005). 131I-labelled-iodized oil for palliative treatment of hepatocellular carcinoma. Eur. J. Gastroenterol. Hepatol., 7, 905-910.
5. Buono, S., Burgio, N., Hamoudeh, M., Fessi, H., Hiltbrand, E., Maciocco, L., & Mehier-Humbert, S. (2007). Brachytherapy: State of the art and possible improvements. Anticancer Agents Med. Chem., 7(4), 411-424.
6. Chu, C. C., & Campbell, N. D. (1982). Scanning electron microscopic study of the hydrolytic degradation of poly(glycolic acid) suture. J. Biomed. Mater. Res., 16, 417-430.
7. Dubernet, C. (1995). Thermoanalysis of microspheres. Thermochim. Acta, 248, 259-269.
8. Even, G. A., & Green, M. A. (1989). Gallium-68-labeled macroaggregated human serum albumin, 68Ga-MAA. Int. J. Rad. Appl. Instrum. B, 16(3), 319-321.
9. Garkavij, M., Samarzija, M., Ewers, S. B., Jakopovic, M., Tezak, S., & Tennvall, J. (2005). Concurrent radiotherapy and tumor targeting with 111In-HMFG1-F(ab')2 in patients with MUC1-positive non-small cell lung cancer. Anticancer Res., 25(6C), 4663-4671.
10. Gilding, D. K., & Reed, A. M. (1979). Biodegradable polymers for use in surgery polyglycolic/poly(actic acid) homo and copolymers. Polymer, 20, 1459-1464.
11. Hafeli, U. O., Roberts, W. K., Pauer, G. J., Kraeft, S. K., & Macklis, R. M. (2001). Stability of biodegradable radioactive rhenium (Re-186 and Re-188) microspheres after neutron-activation. Appl. Radiat Isot., 54, 869-879.
12. Hafeli, U. O., Sweeney, S. M., Beresford, B. A., Sim, E. H., & Macklis, E. M. (1994). Magnetically directed poly(lactic acid) 90Y-microspheres: Novel agents for targeted intracavitary radiotherapy. J. Biomed. Mater. Res., 28(8), 901-908.
13. Hamoudeh, M., Al Faraj, A., Canet-Soulas, E., Bessueille, F., Léonard, D., & Fessi, F. (2007a). Elaboration of PLLA-based superparamagnetic nanoparticles: Characterization, magnetic behaviour study and in vitro relaxivity evaluation. Int. J. Pharm., 338(1-2), 248-257.
14. Hamoudeh, M., & Fessi, H. (2006). Preparation, characterization and surface study of poly-epsilon caprolactone magnetic microparticles. J. Colloid Interf. Sci., 300, 584-590.
15. Hamoudeh, M., Fessi, H., Mehier, H., Al Faraj, A., & Canet-Soulas, E. (2007c). Dirhenium decacarbonyl-loaded PLLA nanoparticles: Influence of neutron irradiation and preliminary in vivo administration by the TMT technique. Int. J. Pharm., 348(1-2), 125-136. doi, 10.1016/j.ijpharm, 010.
16. Hamoudeh, M., Salim, H., Barbos, D., Paunoiu, C., & Fessi, H. (2007b). Preparation and characterization of radioactive dirhenium decacarbonyl-loaded PLLA nanoparticles for radionuclide intratumoral therapy. Eur. J. Pharm. Biopharm., 67(3), 597-611.
17. Hiltbrand, E., Belenger, J., Binzoni, T., Buchegger, F., Costa, M., & Mehier, H. (2004). A new method of thermoablation with hot water vapour for localized tumours. Anticancer Res., 24, 2757-2763.
18. Hiltbrand, E., Belenger, J., Binzoni, T., Buchegger, F., Fessi, H., Costa, M., Quash, G., Foray, J., & Mehier, H. (2003). Thérapie focalisée par microinjections haute pression à l'aide d'un microtube implantable. ITBM-RBM, 24, 136-144.
19. Kaylie, D. M., Stevens, K. R., Kang, M. Y., Cohen, J. I., Wax, M. K., & Andersen, P. E. (2000). External beam radiation followed by planned neck dissection and brachytherapy for base of tongue squamous cell carcinoma. Laryngoscope, 110, 1633-1636.
20. Kobeiter, H., Georgiades, C. S., Leakakos, T., Torbenson, M., Hong, K., & Geschwind, J. F. (2007). Targeted transarterial therapy of vx-2 rabbit liver tumor with yttrium-90 labeled ferromagnetic particles using an external magnetic field. Anticancer Res., 27(2), 755-760.
21. Kwon, H. Y., Lee, J. Y., Choi, S. W., Jang, Y., & Kim, J. H. (2001). Preparation of PLGA nanoparticles containing estrogen by emulsification- diffusion method. Colloid Surf. A, 182, 123-130.
22. Kyoung, P. E., Sang Bong, L., & Moo, Y. (2005). Preparation and characterization of methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials, 6, 1053-1061.
23. 4 particles by precipitation in the presence of PVA at high pH. J. Colloid Interface Sci, 177, 490-494.
24. Loo, S. C. J., Ooi, C. P., & Boey, Y. C. F. (2004). Radiation effects on poly(lactide-co-glycolide) (PLGA) and poly(-lactide) (PLLA). Polym. Degrad. Stabil., 83, 259-265.
25. Milicevic, D., Trifunovic, S., Galovic, S., & Suljovrujic, E. (2007). Thermal and crystallization behaviour of gamma irradiated PLLA. Radiat. Phys. Chem, 76, 1376-1380.
26. Mumper, R. J., & Jay, M. (1992). Poly(L-lactic acid) microspheres containing neutron-activatable holmium-165: A study of the physical characteristics of microspheres before and after irradiation in a nuclear reactor. Pharm. Res., 9, 149-154.
27. Mumper, R. G., Ryo, U. Y., & Jay, M. (1991). Neutron-activated holmium-166-poly (L-lactic acid) microspheres: A potential agent for the internal radiation therapy of hepatic tumors. J. Nucl. Med, 32(11), 2139-2143.
28. Nijsen, J. F., van Het Schip, A. D., van Steenbergen, M. J., Zielhuis, S. W., Kroon-Batenburg, L. M., van de Weert, M., van Rijk, P. P., & Hennink, W. E. (2002). Influence of neutron irradiation on holmium acetyl-acetonate loaded poly(L-lactic acid) microspheres. Biomaterials, 23(8), 1831-1839.
29. Nijsen, J. F., van Steenbergen, M. J., Kooijman, H., Talsma, H., Kroon-Batenburg, L. M., van De Weert, M., van Rijk, P. P., De Witte, A., Van Schip, A. D., & Hennink, W. E. (2001). Characterization of poly(L-lactic acid) microspheres loaded with holmium acetylacetonate. Biomaterials, 22(22), 3073-3081.
30. Nijsen, J. F., Zonnenberg, B. A., Woittiez, J. R., Rook, D. W., Swildens-van Woudenberg, I. A., van Rijk, P. P., & van het Schip, A. D. (1999). Holmium-166 poly lactic acid microspheres applicable for intraarterial radionuclide therapy of hepatic malignancies: Effects of preparation and neutron activation techniques. Eur. J. Nucl. Med., 26, 699-704.
31. Paragkumar, N. T., Edith, D., & Six, J. L. (2006). Surface characteristics of PLLA and PLGA films. Appl. Surf. Sci., 253, 2758-2764.
32. Redenti, E., Peveri, T., Zanol, M., Ventura, P., Gnappi, G., & Montenero, A. (1996). A study on the differentiation between amorphous piroxicam:â-Cyclodextrin complex and a mixture of the two amorphous components. Int. J. Pharm., 129(1-2), 289-294.
33. Rivard, M. J. (2007). Brachytherapy dosimetry parameters calculated for a 131Cs source. Med. Phys., 34(2), 754-762.
34. Roux, C., Rauber, N., Hiltbrand, E., Belenger, J., Khan, H., Dfouni, N., Michel, N., Knopf, J. F., Foray, J., & Mehier, H. (2006). Experimental study on a large animal model of a new thermoablation technique. Anticancer Res., 26, 1-8.
35. Sahoo, S. K., Panyam, J., Prabha, S., & Labhasetwar, V. (2002). Residual polyvinyl alcohol associated with poly (D,L,-lactide-co- glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Release, 82, 105-114.
36. Salem, R., & Hunter, R. D. (2006). Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: A review. Int. J. Radiat. Oncol. Biol. Phys., 66(2), S83-S88.
37. Schenter, R. (2007). From the Nuclear Medicine Research Council website. http://www.personal.psu.edu/jab5021/radioactive%20isotopes.htm (01 March 2008).
38. Schubiger, P. A., Beer, H. F., Geiger, L., Rösler H., Zimmermann, A., Triller, J., Mettler, D., & Schilt, W. (1991). 90y-resin particles-animal experiments on pigs with regard to the introduction of superselective embolization therapy. Int. J. Rad. Appl. Instrum. B, 18(3), 305-311.
39. Siedler, M., Kitchin, S. G., Harris, K. D. M., Lagoa, A. L. C., Diogo, H. P., Manuel, E., da Piedade, M., & Epple, M. (2001). Porous poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) produced by thermal salt elimination from halogenocarboxylates. J. Chem. Soc. Dalton Trans., 3140-3148. http://www.rsc.org/publishing/journals/DT/article.asp? doi=b104979h.
40. Sintzel, M. B., Merkli, A., Tabatabay, C., & Gurny, R. (1997). Influence of irradiation sterilization on polymers used as drug carriers. Drug Dev. Ind. Pharm., 23, 857-878.
41. Sosnowski, S. (2002). Poly(L-lactide) microspheres with controlled crystallinity. Polymer, 42, 637-643.
42. Tayade, P. T., & Kale, R. D. (2004). Encapsulation of water-insoluble drug by a cross-linking technique: Effect of process and formulation variables on encapsulation efficiency, particle size, and in vitro dissolution rate. AAPSPharmSci., 6, E12.
43. Volland, C., Wolff, M., & Kissel, T. (1994). The influence of terminal gamma-sterilization on captopril containing poly(-lactide-co-glycolide) microspheres. J. Control. Release, 31, 293-305.
44. Wunderlich, J., Pinkert, M., Andeeff, M., Stintz, F. F., Knapp, J. K., & Franke, W. G. (2000). Preparation and biodistribution of rhenium-188 labeled albumin microspheres. Appl. Radiat. Isot, 52, B20.
45. Zhang, H., & Shen, G. (2007). Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro. Int. J. Pharm., 329(1-2), 122-128.